Novel Treatment Advances in Differentiated Thyroid Cancer
An overview of therapies in the pipeline for differentiated thyroid cancer and their potential effect on clinical decision-making.
Read More
Dr. Busaidy on the Association Between THST and Improved Outcomes
October 31st 2014Naifa L. Busaidy, MD, associate professor, MD Anderson Cancer Center, discusses the results of a cooperative study that investigated the association between long-term thyroid hormone suppression therapy and improved outcomes in patients.
Read More